The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
Open accessAbstract
Antibodies that immunoprecipitate (125)I-alpha-dendrotoxin-labelled voltage-gated potassium channels extracted from mammalian brain tissue have been identified in patients with neuromyotonia, Morvan's syndrome, limbic encephalitis and a few cases of adult-onset epilepsy. These conditions often improve following immunomodulatory therapies. However, the proportions of the different syndromes, the numbers with associated tumours and the relationships with potassium channel subunit antibody specificities have been unclear. We documented the clinical phenotype and tumour associations in 96 potassium channel antibody positive patients (titres >400 pM). Five had thymomas and one had an endometrial adenocarcinoma. To define the antibody specificities, we looked for binding of serum antibodies and their effects on potassium channel currents using human embryonic kidney cells expressing the potassium channel subunits. Surprisingly, only three of the patients had antibodies directed against the potassium channel subunits. By contrast, we found antibodies to three proteins that are complexed with (125)I-alpha-dendrotoxin-labelled potassium channels in brain extracts: (i) contactin-associated protein-2 that is localized at the juxtaparanodes in myelinated axons; (ii) leucine-rich, glioma inactivated 1 protein that is most strongly expressed in the hippocampus; and (iii) Tag-1/contactin-2 that associates with contactin-associated protein-2. Antibodies to Kv1 subunits were found in three sera, to contactin-associated protein-2 in 19 sera, to leucine-rich, glioma inactivated 1 protein in 55 sera and to contactin-2 in five sera, four of which were also positive for the other antibodies. The remaining 18 sera were negative for potassium channel subunits and associated proteins by the methods employed. Of the 19 patients with contactin-associated protein-antibody-2, 10 had neuromyotonia or Morvan's syndrome, compared with only 3 of the 55 leucine-rich, glioma inactivated 1 protein-antibody positive patients (P < 0.0001), who predominantly had limbic encephalitis. The responses to immunomodulatory therapies, defined by changes in modified Rankin scores, were good except in the patients with tumours, who all had contactin-associated-2 protein antibodies. This study confirms that the majority of patients with high potassium channel antibodies have limbic encephalitis without tumours. The identification of leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 as the major targets of potassium channel antibodies, and their associations with different clinical features, begins to explain the diversity of these syndromes; furthermore, detection of contactin-associated protein-2 antibodies should help identify the risk of an underlying tumour and a poor prognosis in future patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
Vincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B., Detert, N., Clover, L., Parkinson, A., Bien, C. G., Omer, S., et al. (2004) · Brain · doi:10.1093/brain/awh077 · Cited by 1,038
Self-citationIrani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035 · cited 2×
“Details on tissues and binding of the serum antibodies to live neurons in culture are provided in the Supplementary Methods and in Irani et al. (2010).”
Self-citationAnti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 897
Paraneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2
Strauss, K. A., Puffenberger, E. G., Huentelman, M. J., Gottlieb, S., Dobrin, S. E., Parod, J. M., Stephan, D. A., & Morton, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052773 · Cited by 630
Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1
Poliak, S., Salomon, D., Elhanany, H., Sabanay, H., Kiernan, B., Pevny, L., Stewart, C. L., Xu, X., Chiu, S.-Y., Shrager, P., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305018 · Cited by 564
Self-citationIgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Leite, M. I., Jacob, S., Viegas, S., Cossins, J., Clover, L., Morgan, B. P., Beeson, D., Willcox, N., & Vincent, A. (2008) · Brain · doi:10.1093/brain/awn092 · Cited by 527
Self-citationPoliak, S., Gollan, L., Martinez, R., Custer, A., Einheber, S., Salzer, J. L., Trimmer, J. S., Shrager, P., & Peles, E. (1999) · Neuron · doi:10.1016/s0896-6273(00)81049-1 · Cited by 526
Self-citationTreatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A., Houghton, D. J., Galetta, S. L., Dichter, M., Alavi, A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 488
Potassium channel antibodies in two patients with reversible limbic encephalitis
Buckley, C., Oger, J., Clover, L., Tüzün, E., Carpenter, K., Jackson, M., & Vincent, A. (2001) · Annals of Neurology · doi:10.1002/ana.1097 · Cited by 444
Self-citationLocalization of Voltage-Gated Ion Channels IN Mammalian Brain
Trimmer, J. S., & Rhodes, K. J. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032102.113328 · Cited by 442
Epilepsy-Related Ligand/Receptor Complex LGI1 and ADAM22 Regulate Synaptic Transmission
Fukata, Y., Adesnik, H., Iwanaga, T., Bredt, D. S., Nicoll, R. A., & Fukata, M. (2006) · Science · doi:10.1126/science.1129947 · Cited by 412
Liguori, R. (2001) · Brain · doi:10.1093/brain/124.12.2417 · Cited by 407
Acquired neuromyotonia: Evidence for autoantibodies directed against K+channels of peripheral nerves
Shillito, P., Molenaar, P. C., Vincent, A., Leys, K., Zheng, W., van den Berg, R. J., Plomp, J. J., Van Kempen, G. T. H., Chauplannaz, G., Wintzen, A. R., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380505 · Cited by 399
Self-citationPotentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Thieben, M. J., Lennon, V. A., Boeve, B. F., Aksamit, A. J., Keegan, M., & Vernino, S. (2004) · Neurology · doi:10.1212/01.wnl.0000122648.19196.02 · Cited by 394
Antibodies and neuronal autoimmune disorders of the CNS
Graus, F., Saiz, A., & Dalmau, J. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5431-9 · Cited by 392
Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy
Morante-Redolat, J. M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1119 · Cited by 344
Schulte, U., Thumfart, J.-O., Klöcker, N., Sailer, C. A., Bildl, W., Biniossek, M., Dehn, D., Deller, T., Eble, S., Abbass, K., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.033 · Cited by 321
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia
Hart, I. K., Waters, C., Vincent, A., Newland, C., Beeson, D., Pongs, O., Morris, C., & Newsom‐Davis, J. (1997) · Annals of Neurology · doi:10.1002/ana.410410215 · Cited by 315
Self-citationClinical spectrum of voltage-gated potassium channel autoimmunity
Tan, K. M., Lennon, V. A., Klein, C. J., Boeve, B. F., & Pittock, S. J. (2008) · Neurology · doi:10.1212/01.wnl.0000312275.04260.a0 · Cited by 281
Serum antibodies in epilepsy and seizure-associated disorders
McKnight, K., Jiang, Y., Hart, Y., Cavey, A., Wroe, S., Blank, M., Shoenfeld, Y., Vincent, A., Palace, J., & Lang, B. (2005) · Neurology · doi:10.1212/01.wnl.0000187129.66353.13 · Cited by 231
Self-citationNeuronal surface antigen antibodies in limbic encephalitis: Clinical–immunologic associations
Graus, F., Saiz, A., Lai, M., Bruna, J., López, F., Sabater, L., Blanco, Y., Rey, M. J., Ribalta, T., & Dalmau, J. (2008) · Neurology · doi:10.1212/01.wnl.0000325917.48466.55 · Cited by 203
Voltage-Gated Potassium Channel Autoimmunity Mimicking Creutzfeldt-Jakob Disease
Geschwind, M. D., Tan, K. M., Lennon, V. A., Barajas, R. F., Haman, A., Klein, C. J., Josephson, S. A., & Pittock, S. J. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1341 · Cited by 193
Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy
Zhou, Y.-D., Lee, S., Jin, Z., Wright, M., Smith, S. E. P., & Anderson, M. P. (2009) · Nature Medicine · doi:10.1038/nm.2019 · Cited by 185
Genetics of autism spectrum disorders
Kumar, R. A., & Christian, S. L. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0029-2 · Cited by 166
Kleopa, K. A., Elman, L. B., Lang, B., Vincent, A., & Scherer, S. S. (2006) · Brain · doi:10.1093/brain/awl084 · Cited by 163
Self-citationIMMUNOTHERAPY-RESPONSIVE SEIZURE-LIKE EPISODES WITH POTASSIUM CHANNEL ANTIBODIES
Irani, S. R., Buckley, C. J., Vincent, A. C., Cockerell, O. C., Rudge, P., Johnson, M. R., & Smith, S. J. M. (2008) · Neurology · doi:10.1212/01.wnl.0000326572.93762.51 · Cited by 141
Self-citationMonaghan, M. M., Trimmer, J. S., & Rhodes, K. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05973.2001 · Cited by 134
Limbic encephalitis: A cause of temporal lobe epilepsy with onset in adult life
Bien, C. G., & Elger, C. E. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.03.011 · Cited by 127
LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11
Sagane, K., Ishihama, Y., & Sugimoto, H. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.387 · Cited by 122
Autoimmune channelopathies and related neurological disorders.
Vincent, A., Lang, B., & Kleopa, K. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.024 · Cited by 118
Self-citationThe epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface
Sirerol-Piquer, M. S., Ayerdi-Izquierdo, A., Morante‐Redolat, J. M., Herranz‐Pérez, V., Favell, K., Barker, P. A., & Pérez‐Tur, J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl421 · Cited by 106
Autoimmune channelopathies: John Newsom-Davis's work and legacy
Vincent, A. C. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.007 · Cited by 11
Self-citation
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationClinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,435
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
Irani, S. R., Michell, A. W., Lang, B., Pettingill, P., Waters, P., Johnson, M. R., Schott, J. M., Armstrong, R. J. E., S. Zagami, A., Bleasel, A., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22307 · Cited by 928
Self-citationMoshé, S. L., Perucca, E., Ryvlin, P., & Tomson, T. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60456-6 · Cited by 905
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
Lancaster, E., Huijbers, M. G. M., Bar, V., Boronat, A., Wong, A., Martinez‐Hernandez, E., Wilson, C., Jacobs, D., Lai, M., Walker, R. W., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22297 · Cited by 737
Self-citation
Metadata
- Authors
- Irani, S. R., Alexander, S., Waters, P., Kleopa, K. A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., & Vincent, A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-27
- Volume
- 133
- Issue
- 9
- Pages
- 2734-2748
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2100252544
- Cited by
- 1,359
- References
- 34
- FWCI
- 42.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.